Syrentis Clinical Research is a multi-specialty clinical research institute which conducts FDA approved clinical trials with an emphasis in CNS disorders (Alzheimer's dementia, Mild Cognitive Impairment (MCI), major depressive disorder, treatment resistant depression, anxiety disorders, insomnia), as well as diabetes mellitus, COPD, peripheral neuropathy, cardiovascular disease, fibromyalgia, hypercholesterolemia, hypertension, chronic pain, endocrine disorders, weight loss, binge eating, metabolic syndrome, claudication, PVD, birth control and dermatologic disorders. Additionally, we assist with the development of new drug delivery systems, including vaccines, inhalers, IM/IV injections, auto-injectors and topical/patch systems. We have conducted studies using medical devices and we conduct Human Factor product evaluations as well as healthy volunteer studies. Over the last decade, Syrentis Clinical Research has successfully conducted over 200 FDA approved clinical trials in Phases I, II, III and IV of development. Our highly qualified team consists of a dedicated site manager, regulatory/quality assurance manager, two PhD psychologists with extensive rater training, six physicians with over 100 years of combined research experience as principal/sub-investigators, multiple clinical coordinators, multiple clinical raters, dedicated front office staff, pharmacy staff, an infusion nurse, a director of marketing/business development, and a team member dedicated to diversity and community outreach. Our goal is to continue to conduct quality clinical research in an ethical manner while focusing on the satisfaction of both sponsors and subjects. Syrentis Clinical Research is located at 1401 N Tustin Ave Suite 130, Santa Ana, California, United States.